Summit Therapeutics
SMMT
$3.86
Share price
8.73%
Change (1 day)
192.42%
Change (1 year)
Categories
Summit Therapeutics (SMMT) - Total debt
Total debt on the balance sheet as of December 2023 : $0.10 B
According to Summit Therapeutics 's latest financial reports the company's total debt is $0.10 B. A company’s total debt is the sum of all current and non-current debts.
Summit Therapeutics - Total debt on balance sheet (from 2018 to 2020)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -79.55% |
| 2022-12-31 | $0.51 B | 18547.12% |
| 2021-12-31 | $2.78 M | 498.28% |
| 2020-12-31 | $0.46 M | |
| 2019-01-31 | $1.31 M | -27.59% |
| 2018-01-31 | $1.82 M | |
| 2009-01-31 | $2.69 M | -51.7% |
| 2008-01-31 | $5.58 M | 118.25% |
| 2007-01-31 | $2.55 M | 6.4% |
| 2006-01-31 | $2.4 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.39 B | 1,216.52% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $16.59 M | -84.36% | 🇺🇸 USA |
 Coherus BioSciences
CHRS | $0.48 B | 353.20% | 🇺🇸 USA |
 Arena Pharmaceuticals
ARNA | N/A | N/A | 🇺🇸 USA |